Showing results (351-360 of 371) with videos related to

Sort By:
Pageof 38
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 7, 2006
Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomibPaul G Richardson, Hannah Briemberg, Sundar Jagannath, et al.
Cell Systems|December 5, 2020
Conserved Epigenetic Regulatory Logic Infers Genes Governing Cell IdentityWoo Jun Shim, Enakshi Sinniah, Jun Xu, et al.
The New England Journal of Medicine|June 27, 2003
A phase 2 study of bortezomib in relapsed, refractory myelomaPaul G Richardson, Bart Barlogie, James Berenson, et al.
Frontiers in Bioengineering and Biotechnology|June 1, 2026
Beyond sequence similarity: toward function-based screening of nucleic acid synthesisGary R Abel, Tessa Alexanian, Craig Bartling, et al.
Npj Quantum Materials|October 6, 2025
Fermi surface and pseudogap in highly doped Sr<sub>2</sub>IrO<sub>4</sub>Y Alexanian, A de la Torre, S McKeown Walker, et al.
Circulation Research|August 15, 2019
Dynamic Chromatin Targeting of BRD4 Stimulates Cardiac Fibroblast ActivationMatthew S Stratton, Rushita A Bagchi, Marina B Felisbino, et al.
Nature Cardiovascular Research|August 28, 2024
A genome-wide CRISPR screen identifies BRD4 as a regulator of cardiomyocyte differentiationArun Padmanabhan, T Yvanka de Soysa, Angelo Pelonero, et al.
Applied Biosafety : Journal of the American Biological Safety Association|September 10, 2025
The Case for Limiting "Sequences of Concern" to Those with Demonstrated Pathogenic FunctionGene D Godbold, Krista L Ternus, Kevin Flyangolts, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Chromatin Remodeling Drives Immune-Fibroblast Crosstalk in Heart Failure PathogenesisMichael Alexanian, Arun Padmanabhan, Tomohiro Nishino, et al.
Pageof 38